coronary artery disease with blood-stasis and toxin
Conditions
Interventions
blood activating group:QiongShao capsule plus placebo
blood activating and detoxifying group:QiongShao capsule plus placebo
Sponsors
Xi Yuan Hospital Affiliated to the China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
35 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Patients who met the diagnostic criteria of UA fell into the low moderate risk group; (2) Having a history of old myocardial infarction or the results of coronary angiography suggest that at least one coronary artery diameter stenosis>=50%; (3) Aged between of 35 and 70; (4) Patients were informed and signed the informed consent.
Exclusion criteria
Exclusion criteria: (1) Undergoing PCI or CABG recently; (2) Having Acute myocardiol infarction or acute cerebrovascular disease within recent 1 month; (3) Complicating severe cardiac valve disease,serious primary diseases or malignancy of hepatic, renal, hematopoietic system or psychosis; (4) Having NYHA class IV Heart failure, EF <35% or requiring continuous mechanical adjuvant treatment; (5) being poor compliance and difficulty in follow-up; (6) Pregnant women or those trying to conceive to or lactating; (7) Inhibiting data collection of spirituality, language or something else; (8) Having autoimmune diseases activity of rheumatoid or Tuberculosis; (9) Having infection, fever, burns, wounds or surgical history.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| symptoms;physical sign;tongue sign;pulse sign;inflammatory cell factors;platelet activation;coagulation factor;fibrinolytic indexes;marks of endothelium injury;oxidative damage index; | — |
Countries
China
Contacts
Public ContactShi Da-Zhuo
Xi Yuan Hospital Affiliated to the China Academy of Chinese Medical Sciences
Outcome results
None listed